IBIO: iBio, Inc. Company Short-Term Debt

Symbol and logo of brand iBio, Inc. (IBIO)

iBio, Inc. develops advanced anti-tumor methods and leverages AI for antibody analysis to mitigate trial risks. Short-term debt obligations help assess the balance between growth leverage and cash gaps, while 0.00 records a new level mark. Revenue is based on licensing and laboratory services. Cyclical resilience is ensured by steady demand for innovative medicine.

IBIO (iBio Inc) Company Short-Term Debts history from 07/04/2022 to 10/29/2026

Metric breakdowns and analytics for iBio Corporation (IBIO)

- current quotes and average value forecast:
Price Chart iBio|IBIO - Fair Value Consensus
- market capitalization information:
Market Value iBio, Inc.|IBIO - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share iBio|IBIO - Book Capitalization|Market Cap to Net Assets Ratio ibioinc.com|IBIO - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital iBio, Inc.|IBIO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity iBio, Inc.|IBIO - Company Total Debt|Debt to Book Capitalization Ratio iBio, Inc.|IBIO - Company Long-Term Liabilities|Company Current Liabilities iBio|Quick Liquidity ibioinc.com
- net income and valuation multiples indicators:
IBIO - Company Profit
Initial company analysis:IBIO - iBio
Manufactured products of iBio, Inc.

The strong pricing power of iBio, Inc. in antibody development via the RubrY AI platform enables the company to raise capital against future contracts with pharma behemoths. By analyzing the current volume of short-term liabilities, an investor assesses the amount of loans maturing within one year, where a declining curve confirms increasing liquidity, while a sharp spike signals solvency risks regarding R&D funding.

Competitor analysis

ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|Short-Term Debt Volume Zenas Corp ZBIO|IMNM: Company Short-Term Debts|GOSS (gossamerbio.com) - Company Short-Term Debt|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|Septerna, Inc. (SEPN) - Short-Term Debt Volume|Company Short-Term Debt Pieris Pharmaceuticals Inc (PVLA)|SVRA - Short-Term Debt|Rigel Pharmaceuticals - Company Current Liabilities|Company Short-Term Loans and Borrowings ANAB|Astria Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume enGene Holdings Inc ENGN|RAPT Therapeutics (RAPT) - Company Short-Term Debt|Company Short-Term Indebtedness JBIO|ACRS (Aclaris Therapeutics) - Company Short-Term Debts|Company Current Liabilities kyvernatx.com (KYTX)|Company Current Liabilities TLSA (Tiziana Life Sciences Ltd)|Short-Term Debt Volume Cabaletta Bio Inc.|Company Short-Term Debts VTYX (Ventyx Bio)|Short-Term Debt Volume Theratechnologies, Inc (THTX)|Avalo Therapeutics, Inc - Company Short-Term Debts|ELDN: Company Short-Term Debt|AGEN: Company Short-Term Debts|CLYM - Short-Term Debt Volume|Company Short-Term Debt Zura Bio|Short-Term Debt aTyr Pharmaceuticals ATYR|Company Short-Term Debt Adagene (ADAG)|IMA: Current Liabilities|Company Short-Term Debts STTK (Shattuck Labs)|Company Short-Term Loans and Borrowings EQ|Connect Pharma - Company Short-Term Debts|IMUX - Company Short-Term Debts|atarabio.com (ATRA) - Company Short-Term Debt|InflaRx - Company Short-Term Loans and Borrowings|Company Short-Term Debt X4 Pharmaceuticals, Inc.|Company Current Liabilities Adicet (ACET)|Company Short-Term Debts CELU|Company Short-Term Debts INmune Bio Corporation (INMB)|Barinthus Biotherapeutics - Company Current Liabilities|Company Short-Term Loans and Borrowings KZR|SAB Biotherapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume Akari Therapeutics PLC AKTX|enlivex.com (ENLV) - Company Short-Term Debt|Company Current Liabilities Q32 Bio|Company Short-Term Debt GeoVax Labs, Inc.|Company Current Liabilities edesabiotech.com (EDSA)|Company Current Liabilities CARM (Carisma Therapeutics)|Company Short-Term Debts XTL Biopharmaceuticals Ltd (XTLB)|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCWB: Company Short-Term Indebtedness|Aptevo - Company Short-Term Debts|Short-Term Debt aimimmuno.com|ADTX: Company Short-Term Debts|GRI - Short-Term Debt Volume|XRTX (XORTX) - Company Short-Term Debts|Company Short-Term Debt HIND|Company Short-Term Debts REVB|Short-Term Debt Volume indaptusrx.com|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|CalciMedica Inc (CALI) - Short-Term Debt|AFMD: Company Current Liabilities|Company Short-Term Loans and Borrowings ALLK (Allakos Inc.)|HOOK: Company Short-Term Debts|IGMS - Short-Term Debt Volume|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Short-Term Indebtedness OCEA (Ocean Biomedical Inc)|Company Short-Term Debts TCBP|Company Current Liabilities Third Harmonic Bio Inc THRD